← Browse by Condition
Medical Condition
b all
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 1, Phase 3
NCT06689917
Recruiting
JY231(JY231) Injection for the Treatment of Relapsed or Refractory B Cell Lymphoma/ Leukemia
Enrollment
20 pts
Location
China
Sponsor
Tongji Hospital
NCT04318678 Phase 1
Recruiting
CD123-Directed T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML)
Enrollment
108 pts
Location
United States
Sponsor
St. Jude Children's Research H...
NCT07441291 Phase 3
Recruiting
CD19 CAR-T vs DLI for Post-HSCT MRD in Ph- ALL: A RCT
Enrollment
70 pts
Location
China
Sponsor
Peking University People's Hos...